Literature DB >> 19417086

Erythropoietin signaling promotes transplanted progenitor cell survival.

Yi Jia1, Renaud Warin, Xiaobing Yu, Reed Epstein, Constance Tom Noguchi.   

Abstract

We examine the potential for erythropoietin signaling to promote donor cell survival in a model of myoblast transplantation. Expression of a truncated erythropoietin receptor in hematopoietic stem cells has been shown to promote selective engraftment in mice. We previously demonstrated expression of endogenous erythropoietin receptor on murine myoblasts, and erythropoietin treatment can stimulate myoblast proliferation and delay differentiation. Here, we report that enhanced erythropoietin receptor expression, as well as exogenous erythropoietin treatment in myoblasts, provided a survival advantage and protection against apoptosis under serum-starvation conditions. When cultured in differentiation medium, expression of the myogenic regulatory proteins shifted toward early differentiation with increased erythropoietin receptor. Expression of early myogenic differentiation proteins Myf-5 and MyoD increased, while later stage protein myogenin decreased. Transplantation of C2C12 myoblasts overexpressing truncated erythropoietin receptor showed more transplanted cell incorporation into muscle fibers in muscular dystrophy mdx mice. These cells also restored dystrophin protein expression in mdx mice at 6 wk after cell treatment that was further increased with exogenous erythropoietin administration. In summary, enhanced erythropoietin receptor expression promotes transplanted cell survival in a mouse model for myoblast transplantation and provides dystrophin expression in mice with muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19417086      PMCID: PMC2735366          DOI: 10.1096/fj.09-130237

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  33 in total

1.  Self-renewal and expansion of single transplanted muscle stem cells.

Authors:  Alessandra Sacco; Regis Doyonnas; Peggy Kraft; Stefan Vitorovic; Helen M Blau
Journal:  Nature       Date:  2008-09-17       Impact factor: 49.962

2.  Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway.

Authors:  Wei Zhao; Claire Kitidis; Mark D Fleming; Harvey F Lodish; Saghi Ghaffari
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

3.  Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia.

Authors:  Norifumi Urao; Mitsuhiko Okigaki; Hiroyuki Yamada; Yasushi Aadachi; Kuniharu Matsuno; Akihiro Matsui; Shinsaku Matsunaga; Kento Tateishi; Tetsuya Nomura; Tomosaburo Takahashi; Tetsuya Tatsumi; Hiroaki Matsubara
Journal:  Circ Res       Date:  2006-04-27       Impact factor: 17.367

4.  Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex.

Authors:  Luke M Judge; Miki Haraguchiln; Jeffrey S Chamberlain
Journal:  J Cell Sci       Date:  2006-03-28       Impact factor: 5.285

5.  Two domains of the erythropoietin receptor are sufficient for Jak2 binding/activation and function.

Authors:  Stéphane Pelletier; Sébastien Gingras; Megumi Funakoshi-Tago; Sherié Howell; James N Ihle
Journal:  Mol Cell Biol       Date:  2006-09-18       Impact factor: 4.272

Review 6.  Stem and progenitor cells in skeletal muscle development, maintenance, and therapy.

Authors:  Bruno Péault; Michael Rudnicki; Yvan Torrente; Giulio Cossu; Jacques P Tremblay; Terry Partridge; Emanuela Gussoni; Louis M Kunkel; Johnny Huard
Journal:  Mol Ther       Date:  2007-03-27       Impact factor: 11.454

7.  beta-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation.

Authors:  Laure Meyer; Bénédicte Deau; Hana Forejtníková; Dominique Duménil; Florence Margottin-Goguet; Catherine Lacombe; Patrick Mayeux; Frédérique Verdier
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

8.  Dominant negative effect of a truncated erythropoietin receptor (EPOR-T) on erythropoietin-induced erythroid differentiation: possible involvement of EPOR-T in ineffective erythropoiesis of myelodysplastic syndrome.

Authors:  R Shimizu; N Komatsu; Y Miura
Journal:  Exp Hematol       Date:  1999-02       Impact factor: 3.084

9.  A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.

Authors:  M O Arcasoy; K W Harris; B G Forget
Journal:  Exp Hematol       Date:  1999-01       Impact factor: 3.084

10.  Competitive engraftment of hematopoietic stem cells genetically modified with a truncated erythropoietin receptor.

Authors:  Fabrizia Urbinati; Francesco Lotti; Giulia Facchini; Monica Montanari; Giuliana Ferrari; Fulvio Mavilio; Alexis Grande
Journal:  Hum Gene Ther       Date:  2005-05       Impact factor: 5.695

View more
  16 in total

1.  GATA-binding protein 4 (GATA-4) and T-cell acute leukemia 1 (TAL1) regulate myogenic differentiation and erythropoietin response via cross-talk with Sirtuin1 (Sirt1).

Authors:  Li Wang; Yi Jia; Heather Rogers; Yun-Ping Wu; Suming Huang; Constance Tom Noguchi
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

2.  EPO-dependent activation of PI3K/Akt/FoxO3a signalling mediates neuroprotection in in vitro and in vivo models of Parkinson's disease.

Authors:  Yu Jia; Shi-Jing Mo; Qi-Qi Feng; Ma-Li Zhan; Li-Si OuYang; Jia-Chang Chen; Yu-Xin Ma; Jia-Jia Wu; Wan-Long Lei
Journal:  J Mol Neurosci       Date:  2014-01-04       Impact factor: 3.444

Review 3.  Mitochondrial biogenesis: regulation by endogenous gases during inflammation and organ stress.

Authors:  Hagir B Suliman; Claude A Piantadosi
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

4.  Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs.

Authors:  Magdalena Kozakowska; Maciej Ciesla; Anna Stefanska; Klaudia Skrzypek; Halina Was; Agnieszka Jazwa; Anna Grochot-Przeczek; Jerzy Kotlinowski; Agnieszka Szymula; Aleksandra Bartelik; Milena Mazan; Oleksandr Yagensky; Urszula Florczyk; Krzysztof Lemke; Anna Zebzda; Grzegorz Dyduch; Witold Nowak; Krzysztof Szade; Jacek Stepniewski; Marcin Majka; Rafal Derlacz; Agnieszka Loboda; Jozef Dulak; Alicja Jozkowicz
Journal:  Antioxid Redox Signal       Date:  2011-10-19       Impact factor: 8.401

5.  Endogenous erythropoietin signaling facilitates skeletal muscle repair and recovery following pharmacologically induced damage.

Authors:  Yi Jia; Norio Suzuki; Masayuki Yamamoto; Max Gassmann; Constance Tom Noguchi
Journal:  FASEB J       Date:  2012-04-09       Impact factor: 5.191

6.  Erythropoietin contributes to slow oxidative muscle fiber specification via PGC-1α and AMPK activation.

Authors:  Li Wang; Yi Jia; Heather Rogers; Norio Suzuki; Max Gassmann; Qian Wang; Alexandra C McPherron; Jeffery B Kopp; Masayuki Yamamoto; Constance Tom Noguchi
Journal:  Int J Biochem Cell Biol       Date:  2013-03-20       Impact factor: 5.085

7.  EPO-receptor is present in mouse C2C12 and human primary skeletal muscle cells but EPO does not influence myogenesis.

Authors:  Séverine Lamon; Evelyn Zacharewicz; Andrew N Stephens; Aaron P Russell
Journal:  Physiol Rep       Date:  2014-03-27

8.  The role and regulation of erythropoietin (EPO) and its receptor in skeletal muscle: how much do we really know?

Authors:  Séverine Lamon; Aaron P Russell
Journal:  Front Physiol       Date:  2013-07-15       Impact factor: 4.566

Review 9.  Erythropoietin action in stress response, tissue maintenance and metabolism.

Authors:  Yuanyuan Zhang; Li Wang; Soumyadeep Dey; Mawadda Alnaeeli; Sukanya Suresh; Heather Rogers; Ruifeng Teng; Constance Tom Noguchi
Journal:  Int J Mol Sci       Date:  2014-06-10       Impact factor: 5.923

10.  Satellite cell response to erythropoietin treatment and endurance training in healthy young men.

Authors:  Andrea Hoedt; Britt Christensen; Birgitte Nellemann; Ulla Ramer Mikkelsen; Mette Hansen; Peter Schjerling; Jean Farup
Journal:  J Physiol       Date:  2015-12-30       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.